Psoriasis and Skin Clinic, Melbourne, Australia.
2nd Medical Faculty, Charles University, Bulovka Hospital, Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
J Biol Regul Homeost Agents. 2016 Apr-Jun;30(2 Suppl 3):21-8.
Psoriasis is a common chronic inflammatory dermatosis that causes significant distress and morbidity. Approximately 50% of patients with cutaneous psoriasis and 90% of patients with psoriatic arthritis demonstrate nail involvement of their psoriasis. Left untreated, nail psoriasis may progress to debilitating nail disease that leads to not only impairment of function but also on quality of life. We report the case of a 50-year-old male patient with recalcitrant nail dystrophies on the fingers since the age of 40, who responded successfully to Dr. Michaels® product family. The patient had a 35-year history of plaque psoriasis localised on the scalp, ears, groin, limbs, and trunk and with psoriatic arthritis. The nail symptoms consisted of onycholysis, onychomycosis, leukonychia, transverse grooves, nail plate crumbling and paronychia of the periungal skin. This case represents the efficacy and safety of the Dr. Michaels® (Soratinex® and Nailinex®) product family with successful resolution of nail dystrophies and surrounding paronychia with no reported adverse events.
银屑病是一种常见的慢性炎症性皮肤病,会导致严重的不适和发病率。大约 50%的皮肤银屑病患者和 90%的银屑病关节炎患者的银屑病会累及指甲。未经治疗,指甲银屑病可能会进展为使人衰弱的指甲疾病,不仅导致功能受损,还会影响生活质量。我们报告了一例 50 岁男性患者的病例,他从 40 岁开始手指上就出现顽固的指甲营养不良,使用 Michaels® 产品系列后成功得到缓解。该患者有 35 年的斑块型银屑病病史,局限于头皮、耳朵、腹股沟、四肢和躯干,并有银屑病关节炎。指甲症状包括甲分离、甲真菌病、白甲、横沟、甲板碎裂和甲周皮肤甲沟炎。该病例代表了 Michaels®(Soratinex®和 Nailinex®)产品系列的疗效和安全性,成功解决了指甲营养不良和周围甲沟炎,无不良反应报告。